Background
Catheter ablation to achieve pulmonary vein isolation (PVI) has emerged as a guideline-recommended treatment option for patients with symptomatic atrial fibrillation (AF) [In recent years, the high-power short-duration (HPSD) ablation strategy has been applied in the treatment of AF to produce the continuous, transmural lesions and limit collateral damages [